22-50626857-A-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP2PP3_Strong
The NM_000487.6(ARSA):c.661T>A(p.Phe221Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,202 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F221V) has been classified as Uncertain significance.
Frequency
Consequence
NM_000487.6 missense
Scores
Clinical Significance
Conservation
Publications
- metachromatic leukodystrophyInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
- metachromatic leukodystrophy, juvenile formInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000487.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ARSA | NM_000487.6 | MANE Select | c.661T>A | p.Phe221Ile | missense | Exon 3 of 8 | NP_000478.3 | ||
| ARSA | NM_001085425.3 | c.661T>A | p.Phe221Ile | missense | Exon 4 of 9 | NP_001078894.2 | |||
| ARSA | NM_001085426.3 | c.661T>A | p.Phe221Ile | missense | Exon 4 of 9 | NP_001078895.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ARSA | ENST00000216124.10 | TSL:1 MANE Select | c.661T>A | p.Phe221Ile | missense | Exon 3 of 8 | ENSP00000216124.5 | ||
| ARSA | ENST00000356098.9 | TSL:1 | c.661T>A | p.Phe221Ile | missense | Exon 4 of 9 | ENSP00000348406.5 | ||
| ARSA | ENST00000395619.3 | TSL:5 | c.661T>A | p.Phe221Ile | missense | Exon 4 of 9 | ENSP00000378981.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461202Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 726868 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Metachromatic leukodystrophy Uncertain:1
The missense variant p.F221I in ARSA (NM_000487.6) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.F221I variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The p.F221I missense variant is predicted to be damaging by both SIFT and PolyPhen2. The phenylalanine residue at codon 221 of ARSA is conserved in all mammalian species. The nucleotide c.661 in ARSA is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at